TY - JOUR
T1 - Narratives from African American/Black, American Indian/Alaska Native, and Hispanic/Latinx community members in Arizona to enhance COVID-19 vaccine and vaccination uptake
AU - Ignacio, Matt
AU - Oesterle, Sabrina
AU - Mercado, Micaela
AU - Carver, Ann
AU - Lopez, Gilberto
AU - Wolfersteig, Wendy
AU - Ayers, Stephanie
AU - Ki, Seol
AU - Hamm, Kathryn
AU - Parthasarathy, Sairam
AU - Berryhill, Adam
AU - Evans, Linnea
AU - Sabo, Samantha
AU - Doubeni, Chyke
N1 - Funding Information: The authors thank the Southwest Interdisciplinary Research Center’s community advisory board, AC3 project team members, Arizona community-based partners, and study participants for supporting this project while managing other issues related to the COVID-19 pandemic. Funding Information: Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Numbers OT2HL156812. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/4
Y1 - 2023/4
N2 - The state of Arizona has experienced one of the highest novel coronavirus disease 2019 (COVID-19) positivity test rates in the United States with disproportionally higher case rates and deaths among African-American/Black (AA/B), American Indian/Alaska Native (Native), and Hispanic/Latinx (HLX) individuals. To reduce disparities and promote health equity, researchers from Arizona State University, Mayo Clinic in Arizona, Northern Arizona University, and the University of Arizona formed a partnership with community organizations to conduct state-wide community-engaged research and outreach. This report describes results from 34 virtually-held focus groups and supplemental survey responses conducted with 153 AA/B, HLX, and Native community members across Arizona to understand factors associated with COVID-19 vaccine hesitancy and confidence. Focus groups revealed common themes of vaccine hesitancy stemming from past experiences of research abuses (e.g., Tuskegee syphilis experiment) as well as group-specific factors. Across all focus groups, participants strongly recommended the use of brief, narrative vaccination testimonials from local officials, community members, and faith leaders to increase trust in science, vaccine confidence and to promote uptake.
AB - The state of Arizona has experienced one of the highest novel coronavirus disease 2019 (COVID-19) positivity test rates in the United States with disproportionally higher case rates and deaths among African-American/Black (AA/B), American Indian/Alaska Native (Native), and Hispanic/Latinx (HLX) individuals. To reduce disparities and promote health equity, researchers from Arizona State University, Mayo Clinic in Arizona, Northern Arizona University, and the University of Arizona formed a partnership with community organizations to conduct state-wide community-engaged research and outreach. This report describes results from 34 virtually-held focus groups and supplemental survey responses conducted with 153 AA/B, HLX, and Native community members across Arizona to understand factors associated with COVID-19 vaccine hesitancy and confidence. Focus groups revealed common themes of vaccine hesitancy stemming from past experiences of research abuses (e.g., Tuskegee syphilis experiment) as well as group-specific factors. Across all focus groups, participants strongly recommended the use of brief, narrative vaccination testimonials from local officials, community members, and faith leaders to increase trust in science, vaccine confidence and to promote uptake.
KW - African American/Black
KW - COVID-19
KW - Indigenous
KW - Latinx
KW - Medical mistrust
KW - Vaccine hesitancy
KW - Vaccine uptake
UR - http://www.scopus.com/inward/record.url?scp=85126874855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126874855&partnerID=8YFLogxK
U2 - 10.1007/s10865-022-00300-x
DO - 10.1007/s10865-022-00300-x
M3 - Article
C2 - 35322313
SN - 0160-7715
VL - 46
SP - 140
EP - 152
JO - Journal of Behavioral Medicine
JF - Journal of Behavioral Medicine
IS - 1-2
ER -